Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:aimsTo |
develop organs from genetically engineered pigs for human transplantation
|
| gptkbp:focusesOn |
gene editing
xenotransplantation |
| gptkbp:foundedBy |
gptkb:Luhan_Yang
gptkb:George_Church |
| gptkbp:foundedIn |
2015
|
| gptkbp:fundedBy |
venture capital investors
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
eGenesis
|
| gptkbp:notableAchievement |
produced gene-edited pigs with inactivated porcine endogenous retroviruses (PERVs)
advanced preclinical studies in xenotransplantation |
| gptkbp:technology |
gptkb:CRISPR
|
| gptkbp:website |
https://egenesisbio.com/
|
| gptkbp:bfsParent |
gptkb:George_Church
|
| gptkbp:bfsLayer |
5
|